Frontotemporal dementia patients with extrapyramidal symptoms have brainstem atrophy and reduced metabolism in certain areas of the brain significantly more often than patients without extrapyramidal ...

To the Editor: In the Current Concepts in Therapy, "Complications from Psychotherapeutic Drugs. I.," which appeared in the February 9 issue of the Journal, reference was made to the treatment tretment ...

An oral compound, SEP-363856, that does not act on dopamine D2 receptors but has agonist activity at trace amine–associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT 1A) receptors, may ...

Pharmacogenetics has been driven by a candidate gene approach. 4 The disadvantage of this approach is that the objects of study are circumscribed by our current understanding of the mechanisms by ...